Alignment Healthcare president sells 122,707 shares

Alignment Healthcare’s president sold shares to cover RSU-related tax withholding and now directly holds 794,606 ALHC shares.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) reported that President Dawn Christine Maroney sold 122,707 shares of common stock on September 11, 2026. The shares were sold at a weighted-average price of $12.68 per share in multiple trades between $12.394 and $13.17 to cover tax withholding obligations arising from the vesting of restricted stock units, and the company notes this was not a discretionary trade. Following these sales, Maroney directly holds 794,606 shares of Alignment Healthcare common stock.

Insider Trade Summary

Net Seller: 122,707 shares

Net Sell 1 txn

Insider Maroney Dawn Christine

Role President

Sold 122,707 shs ($1.56M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	122,707	$12.68	$1.56M

Holdings After Transaction: Common Stock — 794,606 shares (Direct)

Footnotes (2)

1. F1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
2. F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.394 to $13.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Key Figures

Shares sold: 122,707 shares Weighted-average sale price: $12.68 per share Sale price range: $12.394–$13.17 per share +2 more

5 metrics

Shares sold 122,707 shares Common stock sold on September 11, 2026 to cover tax withholding

Weighted-average sale price $12.68 per share Average price for the 122,707 shares sold on September 11, 2026

Sale price range $12.394–$13.17 per share Range of prices for multiple transactions included in the reported sale

Shares held after transaction 794,606 shares Direct holdings of President Dawn Christine Maroney after the sale

Net shares sold 122,707 shares Net sell activity in the Form 4 transaction summary

Key Terms

restricted stock units, tax withholding obligations, weighted-average price

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"shares required to be sold ... to cover tax withholding obligations"

weighted-average price financial

"The reported price in column 4 is a weighted-average price"

Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ALHC report for President Dawn Christine Maroney?

ALHC reported that President Dawn Christine Maroney sold 122,707 shares of common stock on September 11, 2026 at a weighted-average price of $12.68 per share. The sale was made to cover tax withholding obligations from vesting restricted stock units.

Was the ALHC insider sale by the president a discretionary trade?

No. The filing states the 122,707 shares were sold to cover tax withholding obligations related to vesting restricted stock units and that the transaction does not represent a discretionary trade by President Dawn Christine Maroney.

How many ALHC shares does the president hold after this Form 4 transaction?

After the reported transaction, President Dawn Christine Maroney directly holds 794,606 shares of Alignment Healthcare, Inc. common stock, according to the Form 4 filing.

What price range were the ALHC shares sold at in this insider sale?

The Form 4 states the shares were sold at a weighted-average price of $12.68 per share, with multiple individual trades executed in a price range from $12.394 to $13.17 per share.

Was the ALHC insider sale under a Rule 10b5-1 trading plan?

The document-level Rule 10b5-1 checkbox is not affirmed, and the footnotes describe the sale as to cover tax withholding obligations, not as a transaction under a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 08:41 PM Accepted by SEC EDGAR 09/11/2026 - 08:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		S		122,707(1)	D	$12.68(2)	794,606	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.394 to $13.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)